Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut Inflammation and/or Tighten Gut Mucosal Barrier |
|||||||
| 申请号 | US15868487 | 申请日 | 2018-01-11 | 公开(公告)号 | US20180273956A1 | 公开(公告)日 | 2018-09-27 |
| 申请人 | Synlogic, Inc.; | 发明人 | Dean Falb; Vincent M. Isabella; Jonathan W. Kotula; Paul F. Miller; | ||||
| 摘要 | Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of treating or preventing autoimmune disorders, inhibiting inflammatory mechanisms in the gut, and/or tightening gut mucosal barrier function are disclosed. | ||||||
| 权利要求 | |||||||
| 说明书全文 | |||||||
QQ群二维码
意见反馈
意见反馈